Hal E. Broxmeyer
Hal E. Broxmeyer (1943/1944 – 8 December 2021) was an American microbiologist. He was a professor at the Mary Margaret Walther Program for Cancer Care Research, and Professor of Microbiology and Immunology at the Indiana University School of Medicine. He received a BS degree from Brooklyn College in 1969 and a PhD from New York University in 1973.[1]
Life and career[edit]
Broxmeyer was internationally recognized for his work on human umbilical cord blood as a source of transplantable hematopoietic stem cells.[2] In 1988, he first coordinated a study in successfully demonstrating clinical utility of cord blood transplantation to cure a hematological disorder of a child (Fanconi anemia) working together with Dra. Gluckman. This intervention took place in Hospital Saint-Louis (Paris) and was successful. [3] Work from his laboratory established the field of clinical cord blood transplantation.
He died from thyroid cancer on 8 December 2021, at the age of 77.[4]
Awards and honors[edit]
- Dirk van Bekkum Award (2002)
- E. Donnall Thomas Prize and Lecture (2006)[5]
- President, American Society of Hematology (2010)[6]
- Elected Fellow of American Association for Advancement of Science (2012)[7]
References[edit]
- ^ "Hal E. Broxmeyer, PhD". medicine.iu.edu. Retrieved 9 July 2020.
- ^ Proc National Academy Science USA. 1989 May; 86(10): pages 3828-32
- ^ New England Journal of Medicine 1989 October 26; 321(17): pages 1174-8
- ^ Indiana University’s Hal Broxmeyer, pioneer of cord blood transplantation, dies at 77
- ^ "E Donnall Thomas Lecture and Prize". Hematology.org. 31 January 2018. Retrieved 8 April 2018.
- ^ "Hal E. Broxmeyer, PhD". Hematology.org. 30 March 2016. Retrieved 8 April 2018.
- ^ Science, American Association for the Advancement of (30 November 2012). "AAAS News and Notes". Science. 338 (6111): 1166–1171. doi:10.1126/science.338.6111.1166.
| Authority control databases: Academics |
|---|
